Financial Daily from THE HINDU group of publications
Wednesday, Jan 04, 2006
Financial Daily from THE HINDU group of publications Wednesday, Jan 04, 2006 |
|
|
|
|
|
|
|
Corporate
-
Announcements Aurobindo HIV drug gets USFDA nod Our Bureau
Hyderabad , Jan. 3 AUROBINDO Pharma Ltd has announced that the United States Food and Drug Administration (USFDA) has granted tentative approval for the company's Nevirapine oral suspension in the 50 mg/5 ml forms. It is indicated for use by paediatric patients with HIV. In a press release, the company said this product is the latest addition to the company's product portfolio for the regulated market and also qualifies under the President's Emergency Plan for AIDS Relief programme. This product is the first generic version of the approved product - the Viramune oral suspension, 50 mg /5 ml - manufactured by Boehringer Ingelheim Pharmaceuticals, the release said. According to the company, Nevirapine is active against the human immunodeficiency virus (HIV) that causes AIDS. It belongs to the class of drugs called the non-nucleoside reverse transcriptase inhibitor, which prevents the AIDS virus from reproducing. The drug is used in combination with other antiretroviral agents for the treatment of HIV-1 infection, the release said.
More Stories on : Announcements
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|